Physician profile
Adham Jurdi
NPI 1447414776
$18,454.68
in general payments reported to CMS, 2019-2025
50 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $3,404 · 2021: $1,777 · 2022: $17.44.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $6,699.42 | 2019 | |
| Foundation Medicine, INC. | $6,329.31 | 2019-2021 | |
| Array Biopharma INC | $1,716.38 | 2020 | |
| Janssen Biotech, INC. | $481.07 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $331.21 | 2019-2021 | |
| Genzyme Corporation | $294.72 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $235.00 | 2019-2021 | |
| Celgene Corporation | $208.78 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $194.08 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $165.81 | 2019-2021 | |
| Seagen INC. | $151.80 | 2020-2021 | |
| Incyte Corporation | $144.07 | 2019-2021 | |
| Eisai INC. | $133.26 | 2019-2021 | |
| Lilly USA, LLC | $122.90 | 2020-2021 | |
| Pfizer INC. | $101.00 | 2019-2021 |
Show all 47 companies
3 companies reported research payments only; those appear in the research section below.
Research and ownership
$238.96 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adham Jurdi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.